The Policy Failure

The tools to reduce tick-borne disease exist in various stages of development — vaccines, biocontrol agents, gene drives, next-generation diagnostics — but none of them are deployed at population scale. The United States has no approved human Lyme disease vaccine, no publicly funded tick control infrastructure, no rapid point-of-care Lyme test, and no gene drive program for any tick species.

This article is still in our research and editorial process and will be published soon. The shape of what it will cover is captured below.

Questions this article will answer

• Why does the US have no Lyme vaccine, no tick control infrastructure, and no rapid test?

While you wait — related published articles

• Vaccines — vaccine development history, pipeline status, efficacy data, and barriers to availability
• Gene Drives — gene drive science, CRISPR research status, containment strategies, and the regulatory landscape

Or browse the broader topic: The Systemic Picture